UW Radiology

Theranostics Fellowship

Thank you for your interest in our new Theranostics program. We are now accepting applications for one fellowship position to begin on July 1, 2025. Please continue reading for more information.

Our Theranostics fellowship provides broad exposure to oncologic nuclear medicine with a focus on radiopharmaceutical therapies and theranostics in the treatment of oncology patients and the role of nuclear medicine diagnostic and PET/CT studies in the diagnosis and management of oncology patients, including integration of PET/CT information with information from other imaging modalities.

The Fred Hutchinson Cancer Center provides a robust environment for such training. Currently, we complete 15-20 oncologic PET/CT studies every day on a single GE Discovery MI PET/CT scanner, one of the most sensitive and advanced scanner in the world in current clinical use. We also have one of the first United Imaging PET/MR scanners installed in the US. We actively perform various clinical PET tracers including F-18 FDG, F-18 FES, Ga-68 or F-18 PSMA and Ga-68 or Cu-64 DOTATATE. The Fred Hutchinson Nuclear Medicine Service also leads and support a number of clinical research studies using novel diagnostic and therapy radiopharmaceuticals.

In 2025 we are planning to open a fully equipped dedicated theranostic unit with 8 treatment bays. Currently, dosimetry studies are performed on one SPECT/CT camera and a state of art multi-detector SPECT/CT will be installed in 2025.  Our PET imaging capacity is planned to increase 2026 with an additional high efficiency PET/CT camera.

Our unit is capable of performing various clinical trials including phase 0/first in-human and phase 3 trials and theranostic fellow is expected to be actively involved in the conduct of these trials. 

Fellows who complete this fellowship training course will have expertise in the following areas:

  • Patient evaluation and safe administration of nuclear medicine therapies, with detailed knowledge of clinical workflows such that they will be equipped to start new clinical services or contribute to optimized workflows of existing clinical nuclear medicine therapy services.
  • Clinical applications and interpretations of standard clinical and novel molecular imaging tests.
  • Clinical research study design approaches, image interpretation, and data analysis.
  • Contributing nuclear medicine expertise to multidisciplinary discussions.

Fellowship application

We are currently accepting applications for 2025 and beyond. Those wishing to apply should send the following documents to Marcus Maurer, Program Administrator for Theranostics, at mjmaurer@uw.edu. Please review our Eligibility and Selection Criteria.

  1. A completed copy of the Theranostics Fellowship Application Form
  2. A copy of your curriculum vitae
  3. A personal statement
  4. Three (3) letters of recommendation
  5. Official copies of USMLE Steps 1-3 results
  6. A copy of your medical school transcript
  7. ECFMG Certificate, if applicable

For information about housing in the Seattle area, please visit: https://hr.uw.edu/housing/affordable-rental-housing/